MML Investors Services’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

MML Investors Services’s Portfolio GNOM Stock Details GNOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-3,920	Closed	-$198K	–	2164
2022 Q4	$198K	Sell	3,920 -9,316	-70%	-$480K	﹤0.01%	2031
2022 Q3	$664K	Sell	13,236 -2,195	-14%	-$124K	0.01%	1287
2022 Q2	$754K	Sell	15,431 -11,045	-42%	-$560K	0.01%	1183
2022 Q1	$1.59M	Buy	+26,476	New	+$1.67M	0.01%	890

Other funds holding GNOM

Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return

PAG

Private Advisor Group Morristown, New Jersey $21.3B AUM 22.13% 1-Year Est. Return

OCM

One Capital Management Westlake Village, California $3.65B AUM 15.32% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Lido Advisors Los Angeles, California $32.7B AUM 19.2% 1-Year Est. Return

PGA

Portland Global Advisors Portland, Maine $938M AUM 13.22% 1-Year Est. Return

PFG

Prosperity Financial Group San Ramon, California $271M AUM 30.27% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

MIG

McGuire Investment Group Wakefield, Rhode Island $885M AUM 47.78% 1-Year Est. Return

MML Investors Services's GNOM Position: Q1 2023 in Review

MML Investors Services sold out of Global X Genomics & Biotechnology ETF (GNOM) in Q1 2023, closing a stake of 3,920 shares — an estimated $198K sold.

MML Investors Services first reported a position in GNOM in Q1 2022 and held it in 4 quarters. The position peaked at $1.59M in Q1 2022. 63 funds tracked by Wall St. Rank hold GNOM as of Q1 2023.

MML Investors Services reported no remaining Global X Genomics & Biotechnology ETF position as of Q1 2023 after selling out during the quarter.
MML Investors Services sold 3,920 Global X Genomics & Biotechnology ETF shares in Q1 2023, an estimated $198K.
MML Investors Services first reported a position in Global X Genomics & Biotechnology ETF in Q1 2022 and held it in 4 quarters.
MML Investors Services's Global X Genomics & Biotechnology ETF position peaked at $1.59M in Q1 2022.
63 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q1 2023.

Based on MML Investors Services's 13F filing for Q1 2023, filed 12 May 2023.